𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

✍ Scribed by Timo Möttönen; Pekka Hannonen; Marjatta Leirisalo-Repo; Martti Nissilä; Hannu Kautiainen; Markku Korpela; Leena Laasonen; Heikki Julkunen; Reijo Luukkainen; Kaisa Vuori; Leena Paimela; Harri Blåfield; Markku Hakala; Kirsti Ilva; Urpo Yli-Kerttula; Kari Puolakka; Pentti Järvinen; Mikko Hakola; Heikki Piirainen; Jari Ahonen; Ilppo Pälvimäki; Sinikka Forsberg; Kalevi Koota; Claes Friman

Book ID
117311586
Publisher
The Lancet
Year
1999
Tongue
English
Weight
126 KB
Volume
353
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of infliximab and methotrexa
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
✍ E. William St. Clair; Désirée M. F. M. van der Heijde; Josef S. Smolen; Ravinder 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 2 views

## Abstract ## Objective To compare the benefits of initiating treatment with methotrexate (MTX) and infliximab (anti–tumor necrosis factor α [anti‐TNFα] monoclonal antibody) with those of MTX treatment alone in patients with rheumatoid arthritis (RA) of ≤3 years' duration. ## Methods RA patient

Delay to institution of therapy and indu
Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
✍ Timo Möttönen; Pekka Hannonen; Markku Korpela; Martti Nissilä; Hannu Kautiainen; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 2 views

## Abstract ## Objective To study the impacts of 1) the delay from the onset of symptoms to the institution of disease‐modifying antirheumatic drug (DMARD) therapy, 2) two treatment strategies (treatment with a combination of DMARDs or with a single drug), and 3) the presence of HLA–DRB1 alleles (

COBRA combination therapy in patients wi
COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention
✍ Robert B. M. Landewé; Maarten Boers; Arco C. Verhoeven; Rene Westhovens; Mart A. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Objective The Combinatietherapie Bij Reumatoide Artritis (COBRA) trial demonstrated that step‐down combination therapy with prednisolone, methotrexate, and sulfasalazine (SSZ) was superior to SSZ monotherapy for suppressing disease activity and radiologic progression of rheumatoid a